Randomised Controlled Treatment Study of Selective Mutism

Status Completed

Clinical Trial Summary

Selective mutism (SM) describes inhibited and withdrawn children who are persistently mute in central situations despite ability to talk. SM may cause great suffering and create problems, both socially and related to learning. SM is associated with social anxiety, neurodevelopmental delay and bilingualism. The prevalence is about .7-8 ‰. Adequate assessment and treatment of SM is seldom provided in the mental health services. SM is considered hard to treat, and randomised treatment studies are lacking. This study will examine the effect of a manual based treatment for SM. The treatment consists of home- and kindergarten /school based interventions including behaviour techniques and psychoeducation. Defocused communication is a general treatment principle. Comorbidity, including neurodevelopmental delay /disorder, and predictors of outcome, will be examined. A pilot study was conducted to ensure the feasibility of the planned effectiveness study. Seven children, aged 3-5 years were included. Six has started treatment, and all talked in the kinder garden within the first 3 months. The present study will have a randomised controlled design with 1. Manual based intervention for 6 months compared to 2. Waiting list controls (3 months), and then manual based intervention. The sample: Children aged 3-9 years consecutively referred to the school psychology- or the mental health services in Oslo and Eastern Norway. Expected N = 24 based on the pilot study, is a sufficient sample size to answer our primary research question. The treatment will be given by a therapist from the research group or by a local clinician under supervision. The study can add essential knowledge on treatment of SM and make effective treatment available to clinicians in the community.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT01002196
Study type	Interventional
Source	Regionsenter for barn og unges psykiske helse
Contact
Status	Completed
Phase	Phase 2
Start date	June 2009
Completion date	December 2011

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT02554929` - Treatment of Social Anxiety Disorder and Selective Mutism	N/A
Completed	`NCT00554749` - What Treatment Works for Children With Selective Mutism?	N/A
Completed	`NCT04585048` - The Efficacy of Integrated Behavioral Therapy for Selective Mutism	N/A
Completed	`NCT04291638` - Evaluating an Online Adjunctive Support Following Intensive Services (OASIS) Strategy for Youth With Selective Mutism	N/A
Completed	`NCT02009839` - Web-Based CBT Protocol for Treatment of Selective Mutism	N/A
Recruiting	`NCT03528109` - Improving Access to Child Anxiety Treatment	N/A
Completed	`NCT02051192` - Brief Behavioral Treatment for Anxiety in Young Children	Phase 1/Phase 2
Completed	`NCT00458198` - Integrated Behavioral Therapy for Treating Children With Selective Mutism	N/A
Completed	`NCT05378711` - Evaluating the Results of Physician and Parent Decisions to Treat Selective Mutism With Fluoxetine	Phase 2
Completed	`NCT03612102` - Evaluating Intensive Group Behavioral Treatment for Children With Selective Mutism	N/A
Completed	`NCT04233905` - Factors Influencing Selective Mutism